Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 3/20 | 0.50 |
| ▸ | MAPK11 | Q15759 | 3/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.50 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.45 |
| ▸ | CDC7 | O00311 | 1/20 | 0.44 |
| ▸ | CDK9 | P50750 | 1/20 | 0.44 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30340909 | 0.85 | MAOB (0.58) | HTR3AHRH4HRH3RXFP1MAOB | |
| SCHEMBL30771693 | 0.85 | PIM1 (0.51) | HTR3AHRH4HRH3RXFP1MAOB | |
| SCHEMBL30771674 | 0.85 | HRH3 (0.56) | HTR3AHRH4HRH3RXFP1MAOB | |
| SCHEMBL30771669 | 0.84 | HTR3A (0.43) | HTR3AHRH4HRH3RXFP1MAOB | |
| SCHEMBL23602952 | 0.83 | HRH3 (0.51) | MAPK11MAPK14AAK1HTR3AHRH4 | |
| SCHEMBL30771687 | 0.83 | PDE10A (0.48) | CSNK1DMAPK11MAPK14AAK1HTR3A | |
| SCHEMBL30771684 | 0.83 | PDE10A (0.45) | HTR3AHRH4HRH3RXFP1KDM4E | |
| SCHEMBL30771681 | 0.83 | CYP11B2 (0.50) | MAOBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL30340903 | 0.82 | MAOB (0.60) | HTR3AHRH4HTR6HRH3MAOB | |
| SCHEMBL27163323 | 0.80 | HRH3 (0.43) | HTR3AHRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081304-B1 | ANTIBACTERIAL QUINOLINES | TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA (PT) | 2024-03-06 | — | — | EP | claimed |
| US-12383548-B2 | Antibacterial quinolines | Tecnimede—Sociedade Técnico-Medicinal, SA (PT) | 2025-08-12 | — | — | US | disclosed |
| US-20230106913-A1 | Antibacterial quinolines | TECNIMEDE - Sociedade Técnico-medicinal, SA (PT) | 2023-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12383548-B2 | Antibacterial quinolines | NQO2, RABGGTB, NQO1 | CSNK1D 3832/4885MAPK11 3929/4885MAPK14 3036/4885 |
| US-20230106913-A1 | Antibacterial quinolines | NQO2, RABGGTB, NQO1 | CSNK1D 3832/4885MAPK11 3929/4885MAPK14 3036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.